Three‐hundred fifty‐eight adults with DS were assessed for longitudinal changes in cholinergic basal forebrain and hippocampal volume, amyloid positron emission tomography (PET), tau PET, and cognitive performance. The gene discussed is MAPT; the disease is Dravet syndrome.